ArticleJournal of digestive diseases2022

The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea.

Bo Ram Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.